Market Overview

Life Tech Reports iGenomics to Buy 32 Ion Proton Next-Gen Sequencers

Related LIFE
Market Wrap For January 16: Markets End Two Day Winning Streak
Life Technologies to Provide Ion Torrent Sequencing Platform to Quest Diagnostic

 Life Technologies Corporation (NASDAQ: LIFE) today announced that iGenomics, a privately held diagnostic service company based in Guangzhou, China, purchased 17 Ion Proton™ sequencers and plans to add 15 more instruments by the end of the year. iGenomics, which also signed a licensing and supply agreement with Life Technologies, will initially use the sequencers for research in aneuploidy screening, but plans to expand into other research applications. 

Posted-In: News


Most Popular

Related Articles (LIFE)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free